These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3171876)

  • 21. Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.
    Tod M; Rocchisani JM
    Comput Methods Programs Biomed; 1996 Jun; 50(1):13-22. PubMed ID: 8835836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis program MULTI(ELS) based on extended nonlinear least squares method for microcomputers.
    Yamaoka K; Tanaka H; Okumura K; Yasuhara M; Hori R
    J Pharmacobiodyn; 1986 Feb; 9(2):161-73. PubMed ID: 3754893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delay differential equations based models in NONMEM.
    Yan X; Bauer R; Koch G; Schropp J; Perez Ruixo JJ; Krzyzanski W
    J Pharmacokinet Pharmacodyn; 2021 Dec; 48(6):763-802. PubMed ID: 34302262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM
    Sukarnjanaset W; Wattanavijitkul T; Jarurattanasirikul S
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):729-736. PubMed ID: 29785609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine.
    Chan Kwong AHP; Calvier EAM; Fabre D; Gattacceca F; Khier S
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):431-446. PubMed ID: 32535847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.
    White DB; Walawander CA; Tung Y; Grasela TH
    J Pharmacokinet Biopharm; 1991 Feb; 19(1):87-112. PubMed ID: 2023111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.
    Yamashita F; Fujita A; Sasa Y; Higuchi Y; Tsuda M; Hashida M
    J Pharm Sci; 2017 Sep; 106(9):2407-2411. PubMed ID: 28450239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
    Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A computationally efficient approach for the design of population pharmacokinetic studies.
    Wang J; Endrenyi L
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):279-94. PubMed ID: 1522481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates.
    de Hoog M; Schoemaker RC; van den Anker JN; Vinks AA
    Ther Drug Monit; 2002 Jun; 24(3):359-65. PubMed ID: 12021626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interactive program for pharmacokinetic modeling.
    Lu DR; Mao F
    J Pharm Sci; 1993 May; 82(5):537-42. PubMed ID: 8360833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
    Johansson ÅM; Ueckert S; Plan EL; Hooker AC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2014 Jun; 41(3):223-38. PubMed ID: 24801864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood.
    Almquist J; Leander J; Jirstrand M
    J Pharmacokinet Pharmacodyn; 2015 Jun; 42(3):191-209. PubMed ID: 25801663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KINI: a one compartment intravenous pharmacokinetic analysis program.
    Franck KR; Bertino JS
    Comput Methods Programs Biomed; 1994 Mar; 42(3):157-65. PubMed ID: 8062548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.
    Ismail M; Sale M; Yu Y; Pillai N; Liu S; Pflug B; Bies R
    J Pharmacokinet Pharmacodyn; 2022 Apr; 49(2):243-256. PubMed ID: 34604941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measures of uncertainty of pharmacokinetic and pharmacodynamic parameter estimates: a new computerized algorithm.
    Guzy S; Hunt CA
    Comput Biomed Res; 1996 Dec; 29(6):466-81. PubMed ID: 9012569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection.
    Sale M; Sherer EA
    Br J Clin Pharmacol; 2015 Jan; 79(1):28-39. PubMed ID: 23772792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics of propofol in children using three different data analysis approaches.
    Kataria BK; Ved SA; Nicodemus HF; Hoy GR; Lea D; Dubois MY; Mandema JW; Shafer SL
    Anesthesiology; 1994 Jan; 80(1):104-22. PubMed ID: 8291699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.